<SEC-DOCUMENT>0001333493-21-000024.txt : 20210311
<SEC-HEADER>0001333493-21-000024.hdr.sgml : 20210311
<ACCEPTANCE-DATETIME>20210311083428
ACCESSION NUMBER:		0001333493-21-000024
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210310
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210311
DATE AS OF CHANGE:		20210311

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			eHealth, Inc.
		CENTRAL INDEX KEY:			0001333493
		STANDARD INDUSTRIAL CLASSIFICATION:	INSURANCE AGENTS BROKERS & SERVICES [6411]
		IRS NUMBER:				770470789
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33071
		FILM NUMBER:		21731935

	BUSINESS ADDRESS:	
		STREET 1:		2625 AUGUSTINE DRIVE, SECOND FLOOR
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95054
		BUSINESS PHONE:		650-584-2700

	MAIL ADDRESS:	
		STREET 1:		2625 AUGUSTINE DRIVE, SECOND FLOOR
		CITY:			SANTA CLARA
		STATE:			CA
		ZIP:			95054
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ehth-20210310.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:710e9fc8-a540-4682-b826-e985a4fa1f47,g:7c32026c-e89f-4943-bf75-62134fa54c91,d:695b9148e7224b4e9e9cf3163640365f--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ehth-20210310</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl80L2ZyYWc6NmY1OTBkZDNlM2FiNDZhZTgxMjAzNjI0NTZlZDUyNjkvdGFibGU6N2RlOTcyMTYwOWNjNGEyMmFlNjRlNGFlNjVhODA0MjYvdGFibGVyYW5nZTo3ZGU5NzIxNjA5Y2M0YTIyYWU2NGU0YWU2NWE4MDQyNl8wLTEtMS0xLTA_ae4cd35b-535d-4197-b688-71ea64e0cedf">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl80L2ZyYWc6NmY1OTBkZDNlM2FiNDZhZTgxMjAzNjI0NTZlZDUyNjkvdGFibGU6N2RlOTcyMTYwOWNjNGEyMmFlNjRlNGFlNjVhODA0MjYvdGFibGVyYW5nZTo3ZGU5NzIxNjA5Y2M0YTIyYWU2NGU0YWU2NWE4MDQyNl8xLTEtMS0xLTA_80fde824-7a89-420b-b94c-fc895b8bf88b">0001333493</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ehth-20210310.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001333493</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-10</xbrli:startDate><xbrli:endDate>2021-03-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i695b9148e7224b4e9e9cf3163640365f_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU3_d4d5b944-bd99-4637-ac64-72baa9ca0642">8-K</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8yMjY_91299d04-a711-4399-8c0f-9b2c260a4942">March 10, 2021</ix:nonNumeric></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzUx_4f7b9d18-313a-4b28-ae7f-733b4ba4168f">EHEALTH, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6YTdjMmVjNjhkM2IyNDQ3ZmIzMzllOWI2NzdhNzYzYzgvdGFibGVyYW5nZTphN2MyZWM2OGQzYjI0NDdmYjMzOWU5YjY3N2E3NjNjOF8xLTAtMS0xLTA_d994b24f-fa91-4b28-b985-167f949b5953">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6YTdjMmVjNjhkM2IyNDQ3ZmIzMzllOWI2NzdhNzYzYzgvdGFibGVyYW5nZTphN2MyZWM2OGQzYjI0NDdmYjMzOWU5YjY3N2E3NjNjOF8xLTEtMS0xLTA_973fec35-acfd-4953-9199-950df1db7a87">001-33071</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6YTdjMmVjNjhkM2IyNDQ3ZmIzMzllOWI2NzdhNzYzYzgvdGFibGVyYW5nZTphN2MyZWM2OGQzYjI0NDdmYjMzOWU5YjY3N2E3NjNjOF8xLTItMS0xLTA_06c4762a-f5ef-4970-9899-1c0bd6190454">56-2357876</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzQ0_2281f36c-2b86-4c79-8c5e-ac3026508cfd">2625 AUGUSTINE DRIVE, SECOND FLOOR</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzUy_324b2e54-8019-41a4-915d-a50523e7388f">SANTA CLARA</ix:nonNumeric>, <ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzUz_c4bdfac8-7f78-47ea-ba21-04b406135cb4">CA</ix:nonNumeric> <ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8zNTI_f0025bf0-9217-42d2-af8a-c92fb30513d3">95054</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> (Address of principal executive offices)&#160;&#160;&#160;&#160;(Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV80Njc_def8644f-aaf7-4561-afdd-a3edd74316f0">650</ix:nonNumeric>) <ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzQ1_ed63e840-77f8-42cb-a3d8-178aca75ad89">584-2700</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report.)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:50.294%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="padding-right:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span><br/></span></div><div style="padding-right:27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzQ3_35aa3af8-f90e-42ac-9f52-425a218a91f7"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzQ3_b2a691f5-35e6-4b13-8168-d6c9135ebcbc">&#9744;</ix:nonNumeric></ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></div><div style="padding-right:27pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU5_3edf3e56-d452-4fa4-a659-451b38a35c30">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></div><div style="padding-left:18pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU2_e4fd3675-a3cb-4733-a85b-5903e938a4be"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU2_e57452ef-a0eb-46a4-a03f-7900dea15456">&#9744;</ix:nonNumeric></ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></div><div style="padding-left:18pt;padding-right:27pt;text-indent:-18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU0_9117dc7f-fb59-4f24-934b-a402e806f6a3">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.852%"><tr><td style="width:1.0%"></td><td style="width:35.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6OTlmMTlkMGU3NDRkNDg5OTlkYzZmODU4OWE4YmU4MDIvdGFibGVyYW5nZTo5OWYxOWQwZTc0NGQ0ODk5OWRjNmY4NTg5YThiZTgwMl8xLTAtMS0xLTA_8a70551e-c9bc-40aa-b067-e9bbf8dc9ba7">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6OTlmMTlkMGU3NDRkNDg5OTlkYzZmODU4OWE4YmU4MDIvdGFibGVyYW5nZTo5OWYxOWQwZTc0NGQ0ODk5OWRjNmY4NTg5YThiZTgwMl8xLTItMS0xLTA_e6c75ecb-bdc2-47a0-a442-9251210d4a22">EHTH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6OTlmMTlkMGU3NDRkNDg5OTlkYzZmODU4OWE4YmU4MDIvdGFibGVyYW5nZTo5OWYxOWQwZTc0NGQ0ODk5OWRjNmY4NTg5YThiZTgwMl8xLTQtMS0xLTA_46523d0f-1c7a-458c-ba76-410150455f15">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2). </span></div><div style="margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzUw_d98e8f4b-099f-4241-8910-581d692ac8b2">&#9744;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i695b9148e7224b4e9e9cf3163640365f_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.912%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1.01</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Entry into a Material Definitive Agreement.</span></div></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 10, 2021, eHealth, Inc. (the &#8220;Company&#8221;) entered into a Cooperation Agreement (the &#8220;Agreement&#8221;) with Hudson Executive Capital LP and certain of its affiliates (collectively, &#8220;Hudson&#8221;).</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-indent:40.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Agreement, the Company has agreed to, among other things, appoint John Hass to the Board of Directors of the Company (the &#8220;Board&#8221;) to serve as a Class I director with a term expiring at the Company&#8217;s 2022 annual meeting of shareholders (the &#8220;2022 Annual Meeting&#8221;) and a member of the strategy committee of the Board. Subject to the terms and conditions of the Agreement, the Company has agreed to cooperate in good faith with Hudson to agree on a second director (the &#8220;Second Director&#8221;) within 45 days of the date of the Agreement, to serve as a Class III director with a term expiring at the Company&#8217;s 2021 annual meeting of shareholders (the &#8220;2021 Annual Meeting&#8221;). The Company has also agreed to nominate the Second Director for re-election at the 2021 Annual Meeting with a term expiring at the Company&#8217;s 2024 annual meeting of shareholders.</span></div><div style="text-indent:40.8pt"><span><br/></span></div><div style="text-indent:40.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">With respect to any annual or special meeting of the Company&#8217;s shareholders during the term of the Agreement, Hudson has agreed to vote the shares of the Company&#8217;s common stock then held by it in accordance with the Board&#8217;s recommendations on director election proposals and any other proposals submitted by the Company or a shareholder, except that Hudson may vote in its discretion on Extraordinary Transactions (as defined in the Agreement).</span></div><div style="text-indent:40.8pt"><span><br/></span></div><div style="text-indent:40.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hudson has also agreed to certain customary standstill provisions prohibiting it from, among other things, (i) soliciting proxies, (ii) acquiring, in the aggregate, beneficial ownership of more than 9.9% of the outstanding shares of the Company&#8217;s common stock, (iii) selling securities of the Company resulting in any third party owning more than 4.9% of the outstanding shares of the Company's common stock, (iv) taking actions to change or influence the Board or management, and (v) exercising certain shareholder rights. The Company and Hudson have further agreed to refrain from making any public statement that disparages or is reasonably likely to damage the reputation of the other party.</span></div><div style="text-indent:40.8pt"><span><br/></span></div><div style="text-indent:40.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Agreement will terminate on the date that is the earlier of (i) December 31, 2021 and (ii) 30 days prior to the nomination deadline for the 2022 Annual Meeting. Each of the Company and Hudson has the right to terminate the Agreement earlier if the other party commits a material breach of the Agreement and such breach is not cured within 15 days after notice or, if such breach is not curable within 15 days, the breaching party has not taken any substantive action to cure within such 15-day period. </span></div><div style="text-indent:40.8pt"><span><br/></span></div><div style="text-indent:40.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 1.01.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i695b9148e7224b4e9e9cf3163640365f_13"></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:8.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.588%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 5.02</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 10, 2021, the Company&#8217;s Board appointed John Hass as a Class I director.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Mr. Hass served as chairman of the board and chief executive officer of Rosetta Stone Inc., a leading provider of technology-based learning solutions, from April 2016 to October 2020. Previously, Mr. Hass served as president of Rosetta Stone Inc. from April 2016 to January 2019 and as interim president and chief executive officer from April 2015 to April 2016. From September 2012 until November 2014, he was a senior advisor to Osmium Partners, LLC, an alternative asset management firm. Mr. Hass was a partner at PEAK6 Investments, L.P., a financial services company, from October 2008 through September 2012 and was the senior financial officer of PEAK6 Investments, L.P. from February 2009 through June 2010. Mr. Hass was the chief executive officer of OptionsHouse, a brokerage company and subsidiary of PEAK6 Investments, L.P., from October 2006 until September 2008. From 1988 to October 2006, he was employed at Goldman, Sachs &amp; Co., a subsidiary of the financial services company, The Goldman Sachs Group, Inc., most recently as a managing director in the investment banking division. In addition, Mr. Hass serves on the board of directors of The University of Chicago Laboratory Schools, serves as member of the Photography Committee of the Art Institute of Chicago and serves as a trustee of The Museum of Contemporary Photography. Mr. Hass received his Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Mr. Hass has been named to the strategy committee of the Board.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No arrangement or understanding exists between Mr. Hass and any other person pursuant to which he was selected as a director.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furthermore, there are no transactions between </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Mr. Hass or any member of his immediate family, on the one hand, and the Company or any of its subsidiaries, on the other hand, that require disclosure under Item 404(a) of Regulation S-K. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 10, 2021, in connection with Mr. Hass&#8217; appointment to the Board as a non-employee director and pursuant to the Company&#8217;s 2014 Equity Incentive Plan, Mr. Hass received an automatic grant of restricted stock units covering 3,553 shares of the Company&#8217;s common stock.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The restricted stock units vest annually over four years from the date of grant.</span></div><div><span><br/></span></div><div id="i695b9148e7224b4e9e9cf3163640365f_141"></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:8.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.588%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7.01</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation FD Disclosure.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 11, 2021, the Company issued a press release announcing its entry into the Agreement. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference into this Item 7.01.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:40.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The information contained in this Item 7.01 and in Exhibit 99.1 attached hereto are being furnished to the Securities and Exchange Commission pursuant to Item 7.01 of Form 8-K and shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall such information or exhibit be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended.</span></div><div style="text-indent:40.8pt"><span><br/></span></div><div id="i695b9148e7224b4e9e9cf3163640365f_19"></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:8.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.588%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Financial Statements and Exhibits.</span></div></td></tr></table></div><div><span><br/></span></div><div style="-sec-extract:summary;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:10.161%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.588%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Description</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="cooperationagreement.htm">Cooperation Agreement, dated March 10, 2021 by and between eHealth, Inc. and Hudson Executive Capital LP, on behalf of itself and its affiliates and its affiliated funds</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:none" href="ex991pressreleasecooperati.htm">Press Release of eHealth, Inc. dated March 11, 2021 (eHealth Enters into Cooperation Agreement with Hudson Executive Capital)</a></span></div></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i695b9148e7224b4e9e9cf3163640365f_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div><span><br/></span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.995%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">eHealth, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 11, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Derek N. Yung</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derek N. Yung</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>cooperationagreement.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iba1f97fc8c7a46228a0870d8531b5d1b_32"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">COOPERATION AGREEMENT</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">March 10, 2021</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Hudson Executive Capital LP</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">c&#47;o Cadwalader, Wickersham &#38; Taft LLP</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">200 Liberty Street</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">New York, New York 10281</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">eHealth, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;), on the one hand, and Hudson Executive Capital LP, on behalf of itself, its affiliates and its affiliated funds (such affiliates and affiliated funds (which, for the avoidance of doubt, shall include HEC Management GP LLC and HEC Master Fund LP), together with Hudson Executive Capital LP, collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Hudson</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;), on the other hand, have agreed to the terms contained in this Cooperation Agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;). This Agreement will take effect as of the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;). For purposes of this Agreement, we refer to each of the Company and Hudson as a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221; and, together, as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9.38pt;text-decoration:underline">Company Board and Related Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:23.26pt;text-decoration:underline">Board Actions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. As of the date of this Agreement, the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) has taken the following actions&#58;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:16.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt">the Board has duly adopted a resolution to increase the size of the Board by one (1) director and duly appointed John Hass to fill the newly created seat (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">First Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) to the Board to serve as a Class I director, which individual is independent of each of the Company and Hudson and will serve a term expiring at the Company&#8217;s 2022 annual meeting of shareholders (including any adjournments or postponements thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Annual Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:12.98pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt">the Board has determined the First Director&#8217;s &#8220;independence&#8221; under the rules and regulations of the Nasdaq Stock Market (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Nasdaq</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;), the SEC rules and regulations and the guidelines of the Company&#8217;s independent registered public accounting firm and in accordance with its customary and generally applicable procedures for evaluating director candidates.</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Additional Independent Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:16.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt">As promptly as practicable following the execution of this Agreement, but in any event no later than forty-five (45) days from the date of this Agreement, the Company and Hudson shall cooperate in good faith to agree upon one (1) additional director (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Second Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221; and, together with the First Director, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Newly Appointed Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221; and each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Newly Appointed Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) to serve as a Class III director, with a term expiring at the Company&#8217;s 2021 annual meeting of shareholders (including any adjournments or postponements thereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Annual Meeting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;).  The Second Director shall be selected from a list of candidates prepared by the Company, and Hudson shall provide input by suggesting names of individuals for consideration as candidates (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Second Director Process</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;).  Upon selection of the Second Director, the Board shall increase the size of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Board at that time by one (1) director and take all action necessary to appoint the Second Director to the Board to serve as a Class III director. </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:12.98pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt">The Board will nominate the Second Director for election to the Board at the Company&#8217;s 2021 Annual Meeting with a term expiring at the Company&#8217;s 2024 annual meeting of shareholders (including any adjournments or postponements thereof).</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:9.79pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt">The Board will determine the Second Director&#8217;s &#8220;independence&#8221; under the rules and regulations of Nasdaq, the SEC rules and regulations and the guidelines of the Company&#8217;s independent registered public accounting firm and in accordance with its customary and generally applicable procedures for evaluating director candidates.</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:23.26pt;text-decoration:underline">Information To Be Provided By Newly Appointed Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. In connection with the foregoing, and as a condition to the Newly Appointed Directors&#8217; appointments to the Board, the Newly Appointed Directors will provide to the Company the information required to be disclosed by directors or director candidates of the Company in proxy statements or other filings under applicable law or stock exchange regulations, information required of all other non-management directors of the Company in connection with assessing eligibility, independence and other criteria applicable to directors or satisfying compliance and legal obligations, and fully completed copies of the Company&#8217;s director candidate questionnaire and other reasonable and customary director onboarding documentation, in each case, that is delivered by all other non-management directors of the Company, and consent to the background checks that are undergone by all other non-management directors of the Company.  The Company confirms that the First Director has previously provided all information required by this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Board Size</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. From the Effective Date and continuing until the appointment of the Second Director, the size of the Board will not be more than nine (9) directors and, following the appointment of the Second Director and continuing until the Expiration Date, the size of the Board will not be more than ten (10) directors.</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:23.26pt;text-decoration:underline">2021 Annual Meeting Nominee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. The Company agrees that the slate of nominees recommended by the Board in the Company&#8217;s proxy statement and on its proxy card relating to the 2021 Annual Meeting shall include the Second Director, Jack L. Oliver and Dale B. Wolf (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Annual Meeting Nominees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;), and no other nominees. The Company shall list the Second Director in the proxy statement and the proxy card prepared, filed and delivered in connection with such meeting and recommend that the Company&#8217;s shareholders vote in favor of the election of the Second Director and otherwise support the Second Director in a manner no less or more rigorous and favorable than the manner in which the Company supports any other nominees.</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:24.54pt;text-decoration:underline">Company Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. The policies, procedures, processes, codes, rules, standards and guidelines applicable to other directors of the Company, including the Corporate Governance Guidelines and Code of Business Conduct, and any other policies applicable to members of the Board, including, but not limited to, policies related to stock ownership, public disclosures and confidentiality (as may be amended from time to time, collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Company Policies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) will be applicable to each Newly Appointed Director during such directors&#8217; term of service. The Company represents and warrants that all Company Policies currently in effect are publicly available on the Company&#8217;s website or have been provided to Hudson or its counsel. For the avoidance of doubt, the Company Policies shall not apply to Hudson or any of their affiliated funds.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Non-Interference</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. The Company will not take any action to frustrate the purposes of this Agreement, including by (i) amending or making any alterations to its organizational documents or any Company Policies or (ii) utilizing any existing or new committee of the Board. </font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Committees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. As of the Effective Date, the Board has duly appointed the First Director to serve on the Strategy Committee of the Board (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Strategy Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;). The First Director or any Successor Director that replaces the First Director on the Board shall continue to serve on the Strategy Committee for so long as he or she is serving as a member of the Board as an independent director and otherwise continues to satisfy the eligibility requirements of such committee that are in place as of the execution of this Agreement, unless otherwise agreed by Hudson in writing.  Upon appointment to the Board, the Board shall duly appoint the Second Director to serve on at least one committee of the Board.  The Second Director or any Successor Director that replaces the Second Director on the Board shall continue to serve on at least one committee of the Board for so long as he or she is serving as a member of the Board as an independent director and otherwise continues to satisfy the eligibility requirements of such committee that are in place as of the execution of this Agreement, unless otherwise agreed by Hudson in writing. Each Newly Appointed Director will have the same access to all Board committee materials and meetings as all the other members of the Board.  The Company shall not form any new committee of the Board unless at least one Newly Appointed Director is a member of such committee or at least one of the Newly Appointed Directors approves the formation of such committee. The appointment and service of the Newly Appointed Directors and any successors on the foregoing committees shall be subject to their continued qualifications to serve on such committees under the Nasdaq Listing Rules, the applicable SEC rules and regulations and the guidelines of the Company&#8217;s independent registered public accounting firm. </font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:25.17pt;text-decoration:underline">Successor Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:16.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt">If the First Director ceases to serve as a member of the Board prior to the Expiration Date due to death or disability, Hudson shall be entitled to select another individual to be appointed to the Board (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">First Director Successor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) following the same process under which Hudson suggested, and the Company vetted, from a pool of candidates to mutually identify the First Director. The First Director Successor shall be independent of each of the Company and Hudson, shall qualify as &#8220;independent&#8221; under the Nasdaq Listing Rules, the SEC rules and regulations and the guidelines of the Company&#8217;s independent registered public accounting firm, and have qualifications, experience and industry expertise that are substantially similar to the First Director (or any First Director Successor) being replaced.  The Company shall take all necessary actions to promptly appoint such First Director Successor to the Board and the applicable committee(s), subject to the approval (not to be unreasonably withheld) of the Nominating and Corporate Governance Committee of the Board, after conducting a good faith and customary process consistent with the Board&#8217;s fiduciary duties (and who satisfies the Company Policies applicable to all directors). All references to &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">First Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">,&#8221; for purposes of this Agreement, shall be deemed references to the First Director Successor that replaced the applicable First Director in the event that a First Director Successor is appointed.</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:12.98pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt">If the Second Director ceases to serve as a member of the Board prior to the Expiration Date, the Company and Hudson shall cooperate in good faith to agree upon another individual to be appointed to the Board (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Second Director Successor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221; and, each of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">the First Director Successor and the Second Director Successor, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Successor Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) following the Second Director Process.  The Company shall take all necessary actions to promptly appoint such Second Director Successor to the Board and the applicable committee(s). All references to &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Second Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">,&#8221; for purposes of this Agreement, shall be deemed references to the Second Director Successor that replaced the applicable Second Director in the event that a Second Director Successor is appointed.</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:9.79pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt"> If the First Director Successor proposed by Hudson is rejected for the permitted reasons described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, Hudson shall be entitled to continue proposing persons as replacement successors to the Board and any such replacement successor shall be promptly appointed to the Board (subject to the Board&#8217;s right to reject such person&#8217;s candidacy as First Director Successor for the permitted reasons described in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">). The onboarding of the First Director Successor will be through a reasonable and customary process no more onerous, burdensome or time consuming than the process for onboarding any other director to the Board, and there will be no procedure, policy or other obstacle implemented with the intent or effect of prejudicing the First Director Successors ability to timely join the Board. The Company shall exercise reasonable best efforts, in cooperation with Hudson, to ensure that any First Director Successor is found independent by the relevant regulatory entities.  </font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:10.42pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt"> Notwithstanding any of the foregoing, Hudson shall not take any action, direct or indirect, to cause either Newly Appointed Director to cease serving as a director, and the rights with respect to the designation of a Successor Director described herein shall be subject to Hudson having aggregate beneficial ownership of at least three percent (3%) of the shares of the common stock of the Company, par value $0.001 per share (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;), outstanding at such time (provided, that for purposes of such calculation, the total outstanding shares of Common Stock as of the date of such determination shall be deemed to be the lesser of (1) the aggregate number of shares of Common Stock outstanding as of the date hereof or (2) the aggregate number of shares of Common Stock outstanding as of the date of such determination (in each case, as equitably adjusted for any combinations, splits, recapitalizations or similar actions)).</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:25.17pt;text-decoration:underline">Shareholder Meetings.</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:16.17pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Meetings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. At any annual or special meeting of shareholders of the Company prior to the Expiration Date (including any action of the shareholders by written consent), Hudson shall, or shall cause its Affiliates, Associates (each as defined in Rule 12b-2 promulgated by the SEC under the Exchange Act of 1934, as amended, and with the rules and regulations thereunder (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;)) or representatives to, appear in person or by proxy at such meeting (or submit written consents) and vote all shares of Common Stock over which Hudson, its Affiliates or Associates has voting power (A) in favor of all directors nominated by the Board for election at any such meeting, (B) in accordance with the Board&#8217;s recommendations with respect to any proposal to be submitted to the shareholders of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, that Hudson shall be permitted to vote in its discretion on any proposal of the Company in respect of any Extraordinary Transaction (as defined below).</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:12.98pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9pt;text-decoration:underline">Interim Special Meetings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. From the Effective Date and continuing until the Expiration Date, the Company shall not call or hold any interim special meeting of shareholders for the purpose of removing and&#47;or replacing the Newly Appointed Directors. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9.38pt;text-decoration:underline">Standstill Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. From the Effective Date and continuing until the Expiration Date (as defined below), Hudson will not, and will cause its controlling and controlled Affiliates not to, directly or indirectly&#58;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:23.26pt">purchase or otherwise acquire, or offer, seek, propose or agree to acquire, beneficial ownership of Common Stock such that, giving effect to such purchase or acquisition, Hudson&#8217;s beneficial ownership of Common Stock would exceed 9.9% of the Common Stock outstanding&#59; </font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt">engage in, or assist in the engagement in, soliciting proxies or written consents of shareholders with respect to, or from the holders of, any shares of Common Stock or any other securities of the Company entitled to vote in the election of directors, or securities convertible into, or exercisable or exchangeable for, such shares or other securities, whether or not subject to the passage of time or other contingencies (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Voting Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;), or make, or in any way participate in (other than by voting its shares of Voting Securities in a way that does not violate this Agreement), any solicitation of any proxy, consent or other authority to vote any Voting Securities with respect to the election of directors or any other matter, otherwise conduct or assist in the conducting of any binding or nonbinding referendum with respect to the Company, or seek to advise or encourage any person in, any proxy contest or any solicitation with respect to the Company not approved and recommended by the Board, including relating to the removal or the election of directors, other than solicitations or actions as a participant in support of all of the Company&#8217;s nominees&#894;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:23.26pt">form, join or in any other way participate in a &#8220;partnership, limited partnership, syndicate or other group&#8221; within the meaning of Section 13(d)(3) of the Exchange Act with respect to any Voting Securities, or deposit any Voting Securities in a voting trust or subject any Voting Securities to any voting agreement or other arrangement of similar effect (other than any such voting trust, arrangement or agreement solely among Hudson and its Affiliates that is otherwise in accordance with this Agreement)&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt">publicly seek to call, or request the call of, a special meeting of the shareholders of the Company or publicly seek to make, or make, a shareholder proposal at any meeting of the shareholders of the Company, or otherwise become a &#8220;participant&#8221; in a &#8220;solicitation,&#8221; as such terms are defined in Instruction 3 of Item 4 of Schedule 14A and Rule 14a-1 of Regulation 14A, respectively, under the Exchange Act, to vote any securities of the Company (including by initiating, encouraging or participating in a &#8220;withhold&#8221; or similar campaign)&#59; </font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:23.26pt">(i) except as expressly permitted by this Agreement, seek, alone or in concert with others, election or appointment to, or representation on, the Board or nominate or propose the nomination of, or recommend the nomination of, any candidate to the Board or (ii) seek, alone or in concert with others, the removal of any member of the Board&#894;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:24.54pt">make any request or submit any proposal to amend or waive any of the terms of this Agreement, in each case which would reasonably be expected to result in a public announcement or public disclosure of such request or proposal or give rise to a requirement to so publicly announce or disclose such request or proposal&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt">advise, encourage or influence any person with respect to the voting of (or execution of a written consent in respect of) or disposition of any securities of the Company&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt">sell or agree to sell, directly or indirectly, through swap or hedging transactions or otherwise, any shares of Common Stock or any derivatives relating to Common Stock to any third party (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Third Party</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) other than a Third Party that (x) is (i) a Party to this Agreement, (ii) a member of the Board or (iii) an officer of the Company or (y) would not, together with its Affiliates, own, control or otherwise have beneficial ownership representing in the aggregate in excess of 4.9% of the shares of Common Stock outstanding at such time as a result of such transfer, except for Schedule 13G filers that are mutual funds, pension funds, index funds or investment fund managers that have not been identified on the most recent &#8220;SharkWatch 50&#8221; list, as published by FactSet and any successor (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">SharkWatch List</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) and are not publicly disclosed Affiliate funds of such a filer on the SharkWatch List&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, that nothing herein shall restrict or limit Hudson&#8217;s ability to sell or otherwise dispose of any shares of Common Stock or any derivatives relating to Common Stock in open market transactions where the identity of the purchaser is not readily available&#894;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:25.17pt">take any action in support of or make any proposal, announcement, statement or request regarding&#58; (A) advising, controlling, changing or influencing the Board or management of the Company, including but not limited to, plans or proposals to change the number or term of directors or to fill any vacancies on the Board, (B) any Extraordinary Transaction or exploration thereof (it being understood that this clause 5(i)(B) shall not restrict Hudson from tendering shares, receiving payment for shares or otherwise participating in any such transaction on the same basis as other shareholders of the Company, or from participating in any such transaction that has been approved by the Board) or (C) any other material change in the Company&#8217;s or any of its subsidiaries&#8217; operations, business, corporate strategy, corporate structure, capital structure or allocation, or share repurchase or dividend policies&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, for the avoidance of doubt, that Hudson and its Affiliates shall be entitled to engage in private discussions with respect to such matters with limited partners or shareholders of Hudson or its Affiliates&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:25.17pt">engage in any short sale or any purchase, sale or grant of any option, warrant, convertible security, stock appreciation right or other similar right (including any put or call option or &#8220;swap&#8221; transaction) with respect to any security (other than in connection with a broad-based market basket or index) that relates to or derives any part of its value from any decline in the market price or value of any securities of the Company, and would result in Hudson (together with its affiliates) failing to have an aggregate net long position (as defined in Rule 14e-4 under the Exchange Act) in the Company&#59; </font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt">communicate with the Company&#8217;s shareholders or others pursuant to Rule 14a-1(l)(2)(iv) under the Exchange Act&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:25.17pt">engage in any course of conduct with the purpose of causing shareholders of the Company to vote contrary to the recommendation of the Board on any matter presented to the Company&#8217;s shareholders for their vote at any meeting of the Company&#8217;s shareholders or by written consent&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:19.42pt">publicly act, including by making public announcements or speaking to reporters or members of the media (whether &#8220;on the record&#8221; or on &#8220;background&#8221; or &#8220;off the record&#8221;), to seek to influence the Company&#8217;s shareholders, management or the Board with respect to the Company&#8217;s policies, operations, balance sheet, capital allocation, marketing approach, business </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">configuration, Extraordinary Transactions, or strategy or to obtain representation on the Board or seek the removal of any director in any manner, except as expressly permitted by this Agreement&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt"> call or seek to call, or request the call of, alone or in concert with others, any meeting of shareholders, whether or not such a meeting is permitted by the Amended and Restated Bylaws (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Bylaws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;), including a &#8220;town hall meeting&#8221;&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt">seek, or encourage or advise any person, to submit nominations in furtherance of a &#8220;contested solicitation&#8221; for the election or removal of directors with respect to the Company or seek, encourage or take any other action with respect to the election, removal or replacement of any directors&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt">demand a copy of the Company&#8217;s list of shareholders or its other books and records or make any request pursuant to Rule 14a-7 under the Exchange Act or under any statutory or regulatory provisions of Delaware providing for stockholder access to books and records (including lists of shareholders) of the Company&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt">make any request or submit any proposal to amend or waive the terms of this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> other than through non-public communications with the Company that would not be reasonably likely to trigger public disclosure obligations for any Party&#59;</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:24.54pt">disclose in a manner that could reasonably be expected to become public any intent, purpose, plan or proposal with respect to any director or the Company&#8217;s management, policies, strategy, operations, financial results or affairs, any of its securities or assets or this Agreement that is inconsistent with the provisions of this Agreement&#59; or</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:23.89pt">enter into any discussions, negotiations, agreements or understandings with any person with respect to the foregoing, or advise, assist, knowingly encourage or seek to persuade any person to take any action or make any statement with respect to any such action, or otherwise take or cause any action or make any statement inconsistent with any of the foregoing.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">The restrictions set forth in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> shall not apply to any Newly Appointed Director acting in his capacity as a director of the Company. The Parties further agree that neither Hudson nor any of its Affiliates shall seek to do indirectly through the Newly Appointed Directors (or any Successor Directors) anything that would be prohibited if done by Hudson or its Affiliates. For the avoidance of doubt, the Parties acknowledge and agree that Hudson intends to continue to engage in non-public discussions with members of management of the Company and the Board and nothing in this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> shall be deemed to prevent or impede such discussions from occurring, so long as such discussion is not intended to, and would not reasonably be expected to, require any public disclosure of such discussion.  The Company shall notify Hudson in writing upon the occurrence of the Expiration Date.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">As used herein &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Extraordinary Transaction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221; means any merger, acquisition, amalgamation, tender offer, exchange offer, recapitalization, restructuring, disposition, distribution, spin-off, asset sale, joint venture or other business combination involving the Company or any of its subsidiaries or that relates to or would result in a Change of Control.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9.38pt;text-decoration:underline">Press Release&#59; Form 8-K&#59; Publicity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. The Parties agree that promptly following the execution and delivery of this Agreement by the Parties, (A) the Company will issue the press release attached to this Agreement as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Press Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) and file a Current Report on Form 8-K in the form previously agreed by the Parties and (B) Hudson will file an amendment to its Schedule 13D in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">the form previously agreed by the Parties. Prior to the Expiration Date, the Company, on the one hand, and Hudson, on the other hand, shall each refrain from making, and shall cause their respective Affiliates and Associates and its and their respective principals, directors, members, general partners, officers, employees, agents and representatives (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Representatives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) not to make, any public statement that constitutes an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-style:italic;font-weight:400;line-height:120%">ad hominem</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> attack on, or that otherwise disparages, impugns or is reasonably likely to damage the reputation of, (i) in the case of statements by Hudson or any of its Representatives, the Company or any of its Affiliates or any of its or their respective officers, directors or employees or any person who has served in any of the foregoing capacities, or (ii) in the case of statements by the Company or any of its Representatives, Hudson or any of its Affiliates or any of its or their respective partners, members, officers, directors or employees or any person who has served in the foregoing capacity. The foregoing sentence shall not restrict the ability of any Party to (1) comply with any subpoena or other legal process or respond to a request for information from any governmental authority with jurisdiction over the Party from whom information is sought or (2) make private statements to directors of the Board, employees of the Company, Hudson or employees of Hudson in a manner in which public dissemination of such statements would not be reasonably anticipated.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9.38pt;text-decoration:underline">Representations of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. The Company represents and warrants to Hudson that (a) the Company has the corporate power and authority to execute and deliver this Agreement and to bind it hereto, (b) this Agreement has been duly and validly authorized, executed and delivered by the Company, constitutes a valid and binding obligation and agreement of the Company, and is enforceable against the Company in accordance with its terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other similar laws affecting creditors&#8217; rights generally and to general principles of equity, regardless of whether considered in a proceeding in equity or at law) and (c) the execution, delivery and performance of this Agreement by the Company does not and will not violate or conflict with (i) any law, rule, regulation, order, judgment or decree applicable to the Company, or (ii) result in any breach or violation of or constitute a default (or an event which with notice or lapse of time or both could constitute such a breach, violation or default) under or pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational document, agreement, contract, commitment, understanding or arrangement to which the Company is a party or by which it is bound.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9.38pt;text-decoration:underline">Representations of Hudson</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. Hudson represents and warrants to the Company that (a) Hudson has the power and authority to execute and deliver this Agreement and to bind itself and its affiliates to this Agreement (and Hudson Executive Capital LP has the power and authority to execute and deliver this Agreement and to bind itself and the entities listed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> to this Agreement), (b) this Agreement has been duly authorized, executed and delivered by Hudson, constitutes a valid and binding obligation of Hudson, and is enforceable against Hudson in accordance with its terms (subject to applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and other similar laws affecting creditors&#8217; rights generally and to general principles of equity, regardless of whether considered in a proceeding in equity or at law), (c) the execution of this Agreement by Hudson does not and will not violate or conflict with (i) any law, rule, regulation, order, judgment or decree applicable to Hudson, or (ii) result in any breach or violation of or constitute a default (or an event which with notice or lapse of time or both could constitute such a breach, violation or default) under or pursuant to, or result in the loss of a material benefit under, or give any right of termination, amendment, acceleration or cancellation of, any organizational document, agreement, contract, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">commitment, understanding or arrangement to which Hudson is a party or by which it is bound, (d) Hudson, together with its Affiliates, beneficially owns (as defined in Rule 13d-3 promulgated by the SEC under the Exchange Act) in the aggregate 1,501,002 shares of Common Stock, (e) except as disclosed on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, Hudson is not a party to any swap or hedging transactions or other derivative agreements of any nature with respect to any Voting Securities&#59; and (f) the Newly Appointed Directors (or any Successor Directors) will not be, and Hudson will not consider the Newly Appointed Directors (or any Successor Directors) to be, stockholder designees or stockholder representatives of Hudson. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9.38pt;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. The term of this Agreement shall commence on the Effective Date and shall continue until the date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;) that is the earlier of (a) December 31, 2021 and (b) the date that is thirty (30) days prior to the deadline under the Bylaws for director nominations and shareholder proposals for the 2022 Annual Meeting&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, that (i) Hudson may earlier terminate this Agreement if the Company commits a material breach of its obligations under this Agreement that (if capable of being cured) is not cured within fifteen (15) days after receipt by the Company from Hudson specifying the material breach, or, if impossible to cure within fifteen (15) days, that the Company has not taken any substantive action to cure within such fifteen (15)-day period, and (ii) the Company may earlier terminate this Agreement if Hudson commits a material breach of this Agreement that (if capable of being cured) is not cured within fifteen (15) days after receipt by Hudson from the Company specifying the material breach, or, if impossible to cure within fifteen (15) days, that Hudson has not taken any substantive action to cure within such fifteen (15)-day period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> that either the Company or Hudson may earlier terminate this Agreement upon the consummation of a Change of Control (as defined below)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">, that no expiration or termination of this Agreement will relieve any Party hereto from any liability for a breach of this Agreement prior to such expiration or termination.  Notwithstanding the foregoing, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> through </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Section 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> shall survive the termination of this Agreement. A &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221; shall be deemed to have taken place if (i) any person is or becomes a beneficial owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the equity interests and voting power of the Company&#8217;s then outstanding equity securities, (ii) as a result of a merger or stock-for-stock transaction the Company&#8217;s stockholders retain less than fifty percent (50%) of the equity interests and voting power of the surviving entity&#8217;s then-outstanding equity securities or (iii) the Company sells all or substantially all of its assets. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9.38pt;text-decoration:underline">Fiduciary Duties&#894; Rights of Newly Appointed Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:23.26pt;text-decoration:underline">Fiduciary Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. Notwithstanding anything in this Agreement to the contrary, nothing contained herein shall require any director to violate his or her fiduciary duties.</font></div><div style="margin-top:9pt;padding-left:18pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:22.61pt;text-decoration:underline">Newly Appointed Director Benefits.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> The Company agrees that the Newly Appointed Directors shall receive (i) the same benefits of director and officer insurance, and any indemnity and exculpation arrangements available generally to the directors of the Board and (ii) such other benefits on the same basis as all other non-management directors on the Board, including, unless otherwise requested by such Newly Appointed Director, having the Company (or legal counsel) prepare and file with the SEC, at the Company&#8217;s expense, any Form 3, Form 4 and Form 5 under Section 16 of the Exchange Act that are required to be filed by each director of the Company. </font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9.38pt;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">.  No later than five (5) business days following the execution of this Agreement, the Company shall reimburse Hudson for its reasonable, documented out-of-pocket fees and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">expenses (including attorney&#8217;s fees and other legal expenses and expenses related to the engagement of other advisors and consultants) incurred by Hudson prior to the Effective Date in connection with its engagement with the Company and the negotiation and execution of this Agreement and the transactions contemplated hereby not to exceed the aggregate amount previously agreed to by the Parties.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:9.38pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. This Agreement may be executed in two or more counterparts, each of which will be considered one and the same agreement and will become effective when counterparts have been signed by each of the Parties and delivered to the other Party (including by means of electronic delivery or facsimile).</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:3.63pt;text-decoration:underline">Specific Performance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. Each Party acknowledges and agrees that irreparable injury to the other Party would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached and that money damages may not be an adequate remedy for such a breach. It is accordingly agreed that each Party may be entitled to seek specific enforcement of, and injunctive relief to prevent any violation of, the terms hereof. Each Party agrees to waive any bonding requirement under any applicable law in the case any other Party seeks to enforce the terms by way of equitable relief.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:3.63pt;text-decoration:underline">APPLICABLE LAW AND JURISDICTION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. THIS COOPERATION AGREEMENT WILL BE GOVERNED BY, AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE WITHOUT REFERENCE TO CONFLICTS OF LAWS PRINCIPLES. EACH OF THE PARTIES IRREVOCABLY AGREES THAT ANY LEGAL ACTION OR PROCEEDING TO ENFORCE THIS COOPERATION AGREEMENT WILL BE BROUGHT EXCLUSIVELY IN (A) THE DELAWARE COURT OF CHANCERY IN AND FOR NEW CASTLE COUNTY, (B) IN THE EVENT (BUT ONLY IN THE EVENT THAT SUCH COURT DOES NOT HAVE SUBJECT MATTER JURISDICTION OVER SUCH ACTION), THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE OR (C) IN THE EVENT (BUT ONLY IN THE EVENT) SUCH COURTS IDENTIFIED IN CLAUSES (A) AND (B) DO NOT HAVE SUBJECT MATTER JURISDICTION OVER SUCH ACTION, ANY OTHER DELAWARE STATE COURT (COLLECTIVELY, THE &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">CHOSEN COURTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#8221;). EACH OF THE PARTIES IRREVOCABLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY SUCH ACTION OR PROCEEDING. EACH OF THE PARTIES HEREBY IRREVOCABLY SUBMITS TO THE PERSONAL JURISDICTION OF THE CHOSEN COURTS, AND IRREVOCABLY WAIVES ANY ARGUMENT THAT THE CHOSEN COURTS ARE AN INCONVENIENT OR IMPROPER FORUM. EACH PARTY CONSENTS TO SERVICE OF PROCESS BY A REPUTABLE OVERNIGHT DELIVERY SERVICE, SIGNATURE REQUESTED, TO THE ADDRESS OF SUCH PARTY&#8217;S PRINCIPAL PLACE OF BUSINESS OR AS OTHERWISE PROVIDED BY APPLICABLE LAW.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:3.63pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. All notices, consents, requests, instructions, approvals and other communications provided for in this Agreement and all legal process in regard hereto shall be in writing and shall be deemed validly given, made or served, (a) if given by email, when such email is transmitted to the email address set forth below or (b) if given by any other means, when actually received during normal business hours at the address specified in this Section&#58;</font></div><div style="margin-top:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">If to the Company&#58;  </font></div><div style="text-indent:18pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">eHealth, Inc. </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">2625 Augustine Drive, Second Floor </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Santa Clara, CA 95054 </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Attention&#58; General Counsel </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Email&#58; &#160;&#160;&#160;&#160;legalreview&#64;ehealthinsurance.com</font></div><div style="margin-top:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">With copies to (which shall not constitute notice)&#58;</font></div><div style="margin-top:9pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Wilson Sonsini Goodrich &#38; Rosati</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">701 Fifth Avenue, Suite 5100</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Seattle, WA 98104</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Attention&#58;  Patrick Schultheis</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Email&#58;       pschultheis&#64;wsgr.com</font></div><div style="margin-top:9pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Vinson &#38; Elkins L.L.P.</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">1114 Avenue of the Americas, 32</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.47pt;font-weight:400;line-height:120%;position:relative;top:-4.02pt;vertical-align:baseline">nd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%"> Floor </font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">New York, NY 10036</font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Attention&#58;  Lawrence S. Elbaum</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">C. Patrick Gadson </font></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Email&#58;        lelbaum&#64;velaw.com</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">      pgadson&#64;velaw.com</font></div><div><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">If to Hudson&#58;  </font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Hudson Executive Capital LP</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">c&#47;o Cadwalader, Wickersham &#38; Taft LLP </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">200 Liberty Street</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">New York, New York 10281</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Attention&#58;  General Counsel  </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Email&#58;        Legal&#64;HudsonExecutive.com  </font></div><div style="text-indent:18pt"><font><br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">With a copy to (which shall not constitute notice)&#58;  </font></div><div style="text-indent:18pt"><font><br></font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Cadwalader, Wickersham &#38; Taft LLP  </font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">200 Liberty St. </font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">New York, New York 10281  </font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Attention&#58; &#160;&#160;&#160;&#160;Richard Brand                   </font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Braden McCurrach </font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">Email&#58;&#160;&#160;&#160;&#160;richard.brand&#64;cwt.com                    </font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">braden.mccurrach&#64;cwt.com</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:3.63pt;text-decoration:underline">Entire Agreement&#894; Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. This Agreement, including exhibits and schedules attached to this Agreement, contains the entire understanding of the Parties with respect to the subject matter hereof. This Agreement may be amended only by an agreement in writing executed by the Parties, and no waiver of compliance with any provision or condition of this Agreement and no consent provided for in this Agreement shall be effective unless evidenced by a written instrument executed </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">by the Party against whom such waiver or consent is to be effective. No failure or delay by a Party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power or privilege hereunder.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:3.63pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. If at any time subsequent to the date of this Agreement, any provision of this Agreement shall be held by any court of competent jurisdiction to be illegal, void or unenforceable, such provision shall be of no force and effect, but the illegality or unenforceability of such provision shall have no effect upon the legality or enforceability of any other provision of this Agreement.</font></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%;padding-left:3.63pt;text-decoration:underline">No Third Party Beneficiaries&#894; Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">. This Agreement is solely for the benefit of the Parties and is not binding upon or enforceable by any other persons. No Party may assign its rights or delegate its obligations under this Agreement, whether by operation of law or otherwise, and any assignment in contravention hereof shall be null and void. Nothing in this Agreement, whether express or implied, is intended to or shall confer any rights, benefits or remedies under or by reason of this Agreement on any persons other than the Parties, nor is anything in this Agreement intended to relieve or discharge the obligation or liability of any third persons to any Party.</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-style:italic;font-weight:400;line-height:120%">Signature Page Follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><div id="iba1f97fc8c7a46228a0870d8531b5d1b_42"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If the terms of this Agreement are in accordance with your understanding, please sign below and this Agreement will constitute a binding agreement among us.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EHEALTH, INC.  </font></div><div style="padding-left:288pt"><font><br></font></div><div style="padding-left:288pt"><font><br></font></div><div style="padding-left:288pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Scott N. Flanders                 </font></div><div style="padding-left:306pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Scott N. Flanders</font></div><div style="padding-left:306pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;  Chief Executive Officer</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Acknowledged and agreed to as of the date first written above&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">HUDSON EXECUTIVE CAPITAL LP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, on behalf of itself, its affiliates and its affiliated funds</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;  &#160;&#160;&#160;&#160;HEC Management GP LLC, its General Partner  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;  &#160;&#160;&#160;&#160;DGB Hudson, LLC, its managing member</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58; &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">      &#47;s&#47; Douglas G. Bergeron                        </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58;&#160;&#160;&#160;&#160;Douglas G. Bergeron </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;&#160;&#160;&#160;&#160;Managing Member</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="iba1f97fc8c7a46228a0870d8531b5d1b_37"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Press Release </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR IMMEDIATE RELEASE</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">eHealth Enters into Cooperation Agreement with Hudson Executive Capital</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANTA CLARA, Calif., </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; March 11, 2021 &#8211; eHealth, Inc. (NASDAQ&#58; EHTH) (&#34;eHealth&#34; or the &#34;Company&#34;) today announced that it has reached an agreement with Hudson Executive Capital LP (&#8220;HEC&#8221;) to immediately appoint one new director and engage in a process to mutually agree upon a second director in the next 45 days.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John Hass, former CEO of Rosetta Stone, was appointed to the Board of Directors (the &#8220;Board&#8221;) effective March 10, 2021. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Hass brings significant experience in executing value-generative transformation and advancing profitable innovation, as well as deep operational and financial expertise. With the addition of Mr. Hass and the expected appointment of an additional member in the near-term, the Company will have added or named for appointment six new directors over the last three years and its Board will consist of 10 members, nine of whom are independent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;eHealth prides itself on its commitment to strong corporate governance and active shareholder engagement. We look forward to welcoming John and an additional independent director to our Board,&#8221; said Scott Flanders, Chief Executive Officer and Director of eHealth. &#8220;This is an important time for eHealth, and we are eager to benefit from the fresh perspectives and valuable insights of our new Board members as we continue building out our capabilities, executing our strategies and positioning our company to capture significant opportunities.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;I am thrilled to join eHealth&#8217;s Board at a time when the Company&#8217;s mission has never been more critical,&#8221; said Mr. Hass. &#8220;eHealth has a unique platform and is well positioned to grow and win market share.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this announcement, eHealth has entered into a cooperation agreement with HEC, which currently owns approximately 6% of the Company&#8217;s outstanding common stock. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Douglas G. Bergeron, Co-Managing Partner of HEC commented, &#8220;We appreciate the constructive dialogue we&#8217;ve had with eHealth over the last several months and to have worked collaboratively with the Board and management team to reach this resolution. We believe that the appointments of two new directors will help the Company focus on its important mission and execution.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to its agreement with the Company, HEC has agreed to customary standstill and voting commitments, among other provisions. The full agreement between HEC and eHealth will be filed on a Form 8-K with the U.S. Securities and Exchange Commission. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">About John Hass </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John Hass most recently served as Chairman of the Board and Chief Executive Officer of Rosetta Stone, leading its transformation from a CD-based language company to a growing, subscription-based educational technology business serving K-12 schools, corporations and consumers. From 1988 to October 2006, he worked at Goldman, Sachs &#38; Co. in roles of increasing responsibility, culminating in serving as a Managing Director in the Investment Banking Division. Mr. Hass received his Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">About eHealth</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eHealth, Inc. (NASDAQ&#58; EHTH) operates a leading health insurance marketplace at eHealth.com and eHealthMedicare.com with technology that provides consumers with health insurance enrollment solutions. Since 1997, we have connected more than 8 million members with quality, affordable health </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance, Medicare options, and ancillary plans. Our proprietary marketplace offers Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual, family, small business and other plans from over 180 health insurance carriers across fifty states and the District of Columbia.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">About Hudson Executive Capital LP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hudson Executive Capital (&#8220;HEC&#8221;) is a New York City-based value-oriented investor focused on engaging with US small and mid-cap public companies with identified and actionable opportunities to create outsized returns. Seasoned operating executives Douglas Braunstein and Douglas Bergeron lead an experienced investment team to help companies catalyze value and drive returns. A group of 30+ current and former public company CEOs are LPs in the fund and support all aspects of the investment model, including idea generation, investment due diligence, and execution. For more information about HEC, please visit </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.hudsonexecutive.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Advisors</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moelis &#38; Company LLC is serving as financial advisor to eHealth and Wilson Sonsini Goodrich &#38; Rosati, Professional Corporation and Vinson &#38; Elkins L.L.P. are serving as its legal advisors. Cadwalader, Wickersham &#38; Taft is serving as legal advisor to HEC.</font></div><div><font><br></font></div><div><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding the appointment of additional directors to the Company&#8217;s board of directors, the benefits of adding new directors and the execution by the Company of its business strategies.</font></div><div><font><br></font></div><div><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made. The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include those described in eHealth's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission and available on the investor relations page of eHealth's website at </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">http&#58;&#47;&#47;www.ehealthinsurance.com</font><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and on the Securities and Exchange Commission's website at </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.sec.gov</font><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All forward-looking statements in this press release are based on information available to eHealth as of the date hereof, and eHealth does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Investor Relations Contact</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kate Sidorovich, CFA</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vice President, Investor Relations</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2625 Augustine Drive, Second Floor</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Santa Clara, CA, 95054</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">650-210-3111</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">kate.sidorovich&#64;ehealth.com</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Media Relations Contact</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lara Sasken</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vice President, Communications</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2625 Augustine Drive, Second Floor</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Santa Clara, CA, 95054</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lara.sasken&#64;ehealth.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Jim Golden &#47; Aaron Palash</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Joele Frank, Wilkinson Brimmer Katcher</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212-355-4449</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="iba1f97fc8c7a46228a0870d8531b5d1b_48"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Hudson Interests</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On February 18, 2021, Hudson purchased 7,505 put options (with each contract having a 100 multiplier) with a strike price of $45 and a maturity date of October 15, 2021 and sold short 7,505 call options (with each contract having a 100 multiplier) with a strike price of $65 and a maturity date of October 15, 2021.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex991pressreleasecooperati.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i64fda0c3c8c24edcb6def507d89a9223_32"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR IMMEDIATE RELEASE</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">eHealth Enters into Cooperation Agreement with Hudson Executive Capital</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANTA CLARA, Calif., </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; March 11, 2021 &#8211; eHealth, Inc. (NASDAQ&#58; EHTH) (&#34;eHealth&#34; or the &#34;Company&#34;) today announced that it has reached an agreement with Hudson Executive Capital LP (&#8220;HEC&#8221;) to immediately appoint one new director and engage in a process to mutually agree upon a second director in the next 45 days.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John Hass, former CEO of Rosetta Stone, was appointed to the Board of Directors (the &#8220;Board&#8221;) effective March 10, 2021. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Hass brings significant experience in executing value-generative transformation and advancing profitable innovation, as well as deep operational and financial expertise. With the addition of Mr. Hass and the expected appointment of an additional member in the near-term, the Company will have added or named for appointment six new directors over the last three years and its Board will consist of 10 members, nine of whom are independent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;eHealth prides itself on its commitment to strong corporate governance and active shareholder engagement. We look forward to welcoming John and an additional independent director to our Board,&#8221; said Scott Flanders, Chief Executive Officer and Director of eHealth. &#8220;This is an important time for eHealth, and we are eager to benefit from the fresh perspectives and valuable insights of our new Board members as we continue building out our capabilities, executing our strategies and positioning our company to capture significant opportunities.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;I am thrilled to join eHealth&#8217;s Board at a time when the Company&#8217;s mission has never been more critical,&#8221; said Mr. Hass. &#8220;eHealth has a unique platform and is well positioned to grow and win market share.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with this announcement, eHealth has entered into a cooperation agreement with HEC, which currently owns approximately 6% of the Company&#8217;s outstanding common stock. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Douglas G. Bergeron, Co-Managing Partner of HEC commented, &#8220;We appreciate the constructive dialogue we&#8217;ve had with eHealth over the last several months and to have worked collaboratively with the Board and management team to reach this resolution. We believe that the appointments of two new directors will help the Company focus on its important mission and execution.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to its agreement with the Company, HEC has agreed to customary standstill and voting commitments, among other provisions. The full agreement between HEC and eHealth will be filed on a Form 8-K with the U.S. Securities and Exchange Commission. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">About John Hass </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">John Hass most recently served as Chairman of the Board and Chief Executive Officer of Rosetta Stone, leading its transformation from a CD-based language company to a growing, subscription-based educational technology business serving K-12 schools, corporations and consumers. From 1988 to October 2006, he worked at Goldman, Sachs &#38; Co. in roles of increasing responsibility, culminating in serving as a Managing Director in the Investment Banking Division. Mr. Hass received his Bachelor of Science in Finance from the University of Illinois at Urbana-Champaign.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">About eHealth</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">eHealth, Inc. (NASDAQ&#58; EHTH) operates a leading health insurance marketplace at eHealth.com and eHealthMedicare.com with technology that provides consumers with health insurance enrollment solutions. Since 1997, we have connected more than 8 million members with quality, affordable health </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance, Medicare options, and ancillary plans. Our proprietary marketplace offers Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual, family, small business and other plans from over 180 health insurance carriers across fifty states and the District of Columbia.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">About Hudson Executive Capital LP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hudson Executive Capital (&#8220;HEC&#8221;) is a New York City-based value-oriented investor focused on engaging with US small and mid-cap public companies with identified and actionable opportunities to create outsized returns. Seasoned operating executives Douglas Braunstein and Douglas Bergeron lead an experienced investment team to help companies catalyze value and drive returns. A group of 30+ current and former public company CEOs are LPs in the fund and support all aspects of the investment model, including idea generation, investment due diligence, and execution. For more information about HEC, please visit </font><font style="color:#026dce;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.hudsonexecutive.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Advisors</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moelis &#38; Company LLC is serving as financial advisor to eHealth and Wilson Sonsini Goodrich &#38; Rosati, Professional Corporation and Vinson &#38; Elkins L.L.P. are serving as its legal advisors. Cadwalader, Wickersham &#38; Taft is serving as legal advisor to HEC.</font></div><div><font><br></font></div><div><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding the appointment of additional directors to the Company&#8217;s board of directors, the benefits of adding new directors and the execution by the Company of its business strategies.</font></div><div><font><br></font></div><div><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made. The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include those described in eHealth's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission and available on the investor relations page of eHealth's website at </font><font style="color:#026dce;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">http&#58;&#47;&#47;www.ehealthinsurance.com</font><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and on the Securities and Exchange Commission's website at </font><font style="color:#026dce;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.sec.gov</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#0a0a0a;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All forward-looking statements in this press release are based on information available to eHealth as of the date hereof, and eHealth does not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Investor Relations Contact</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kate Sidorovich, CFA</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vice President, Investor Relations</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2625 Augustine Drive, Second Floor</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Santa Clara, CA, 95054</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">650-210-3111</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">kate.sidorovich&#64;ehealth.com</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Media Relations Contact</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lara Sasken</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vice President, Communications</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2625 Augustine Drive, Second Floor</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Santa Clara, CA, 95054</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lara.sasken&#64;ehealth.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Jim Golden &#47; Aaron Palash</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Joele Frank, Wilkinson Brimmer Katcher</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">212-355-4449</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ehth-20210310.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:710e9fc8-a540-4682-b826-e985a4fa1f47,g:7c32026c-e89f-4943-bf75-62134fa54c91-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ehth="http://www.ehealthinsurance.com/20210310" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ehealthinsurance.com/20210310">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210310_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210310_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210310_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ehth-20210310_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.ehealthinsurance.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>ehth-20210310_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:710e9fc8-a540-4682-b826-e985a4fa1f47,g:7c32026c-e89f-4943-bf75-62134fa54c91-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="simple" xlink:href="ehth-20210310.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>ehth-20210310_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:710e9fc8-a540-4682-b826-e985a4fa1f47,g:7c32026c-e89f-4943-bf75-62134fa54c91-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="simple" xlink:href="ehth-20210310.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="extended" id="i6792d98fbfb14ab497edfbd9d8cf3239_CoverPage"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>ehth-20210310_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:710e9fc8-a540-4682-b826-e985a4fa1f47,g:7c32026c-e89f-4943-bf75-62134fa54c91-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_0ef24f6a-a3e6-40e0-b15e-1237c67fc954_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_80a52e99-87ad-47ce-8702-e0bd9b5ed1dd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_cf78b491-41f0-4e37-8556-704134fe3023_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_56b9a9bd-f404-43d2-ae6e-2d56241579fc_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c4e01f3b-e679-438d-acd9-5c3098869d3a_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0f575efb-4546-4da5-b779-24fb0ae41a70_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bd50c338-bb8a-42e5-b0c2-7f9bff5a223a_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_bc51eef9-aedc-41c0-9b62-44553d45c1be_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_62cc3095-3e33-4c5a-ab54-a32eb0c70aab_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_3ceb897e-09dc-4142-bd07-a4e5e4f2e70a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c7880085-4a3b-4363-9438-2ca8a3558683_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_1598cc41-9638-4f1e-9590-ded8069d2296_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_39659dab-ac1a-40c1-a08b-223a1db1afc3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_c20d0d7e-892b-4e36-945a-c02425ce9a92_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_0aec4108-53a7-4f75-a4de-c2e9e5eba724_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e27b21b8-5d54-4a0b-835b-474cc207256e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f9edb1f6-5576-4ad6-9cfa-f23283598d4f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_256a9710-dabf-4c1f-8c5f-183a3d0050f0_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_78d371c0-6530-4a89-ad86-84dda8767d9d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_24f5609b-b29b-4c27-b54a-8077fb3e7bd8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_851c96f9-5dde-4fc0-88c4-8a4e553f8511_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f84ba7c6-e847-4334-81d9-35d9c9a816bd_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>ehth-20210310_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:710e9fc8-a540-4682-b826-e985a4fa1f47,g:7c32026c-e89f-4943-bf75-62134fa54c91-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="simple" xlink:href="ehth-20210310.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.ehealthinsurance.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6d7c26f4-4905-494b-a695-b2b9e6aa9957" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_DocumentType_6d7c26f4-4905-494b-a695-b2b9e6aa9957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d548526f-58f7-428c-b644-b016d3fa9e4c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_DocumentPeriodEndDate_d548526f-58f7-428c-b644-b016d3fa9e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_dc6814e8-56f1-4286-a1ac-51306d36709c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityRegistrantName_dc6814e8-56f1-4286-a1ac-51306d36709c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8de229f1-a3e0-420f-a8f3-d9e13a6e4f34" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8de229f1-a3e0-420f-a8f3-d9e13a6e4f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_fd6d8467-d6aa-44bd-81bf-04557bc39923" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityFileNumber_fd6d8467-d6aa-44bd-81bf-04557bc39923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_85987cf9-16d8-4bf8-b67b-af8db411dab9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityTaxIdentificationNumber_85987cf9-16d8-4bf8-b67b-af8db411dab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6922a107-d773-4dec-93e9-0a4ff09f9c31" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityAddressAddressLine1_6922a107-d773-4dec-93e9-0a4ff09f9c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4e5e5d10-7ea6-4e30-8426-8ca94683c261" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityAddressCityOrTown_4e5e5d10-7ea6-4e30-8426-8ca94683c261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fa401599-608e-4fe1-b960-2521e9f2521b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityAddressStateOrProvince_fa401599-608e-4fe1-b960-2521e9f2521b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1270c0f6-13d3-4a79-b58c-3443cee05840" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityAddressPostalZipCode_1270c0f6-13d3-4a79-b58c-3443cee05840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0b1701df-d2f2-4654-aa90-e5040c567200" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_CityAreaCode_0b1701df-d2f2-4654-aa90-e5040c567200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4fb852b8-2ab8-45ab-9dec-de6ef7fe2ad0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_LocalPhoneNumber_4fb852b8-2ab8-45ab-9dec-de6ef7fe2ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_cdf4b0ee-c839-41f6-98e3-3f219f308da4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_WrittenCommunications_cdf4b0ee-c839-41f6-98e3-3f219f308da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_f1d9b16c-a978-4ae1-91a8-24d232a9c040" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_SolicitingMaterial_f1d9b16c-a978-4ae1-91a8-24d232a9c040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_10e94f40-4210-4421-a585-06e876313b80" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_PreCommencementTenderOffer_10e94f40-4210-4421-a585-06e876313b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_48f69afc-315f-4e98-8939-3a057b00b58b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_Security12bTitle_48f69afc-315f-4e98-8939-3a057b00b58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_a8e8bddc-3a74-4a7f-b978-77051a6b90d5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_a8e8bddc-3a74-4a7f-b978-77051a6b90d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_bcbe8a46-d1c3-4d42-81d2-17a9a5881c7f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_TradingSymbol_bcbe8a46-d1c3-4d42-81d2-17a9a5881c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_807ae43e-d67a-4369-ac8a-38c5a5a6f92d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_SecurityExchangeName_807ae43e-d67a-4369-ac8a-38c5a5a6f92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5468514d-9cdb-42c3-8616-78134e62d823" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityEmergingGrowthCompany_5468514d-9cdb-42c3-8616-78134e62d823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_28e9ee45-acb8-4cbe-ab94-88ae526f3fb6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_AmendmentFlag_28e9ee45-acb8-4cbe-ab94-88ae526f3fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_865fd32c-42e7-40af-b53e-5ff5fb40809d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e7cb4cf8-7288-4826-846c-c601d4713534" xlink:to="loc_dei_EntityCentralIndexKey_865fd32c-42e7-40af-b53e-5ff5fb40809d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>ehth-20210310_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ehth-20210310.xsd" xlink:type="simple"/>
    <context id="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001333493</identifier>
        </entity>
        <period>
            <startDate>2021-03-10</startDate>
            <endDate>2021-03-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl80L2ZyYWc6NmY1OTBkZDNlM2FiNDZhZTgxMjAzNjI0NTZlZDUyNjkvdGFibGU6N2RlOTcyMTYwOWNjNGEyMmFlNjRlNGFlNjVhODA0MjYvdGFibGVyYW5nZTo3ZGU5NzIxNjA5Y2M0YTIyYWU2NGU0YWU2NWE4MDQyNl8wLTEtMS0xLTA_ae4cd35b-535d-4197-b688-71ea64e0cedf">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl80L2ZyYWc6NmY1OTBkZDNlM2FiNDZhZTgxMjAzNjI0NTZlZDUyNjkvdGFibGU6N2RlOTcyMTYwOWNjNGEyMmFlNjRlNGFlNjVhODA0MjYvdGFibGVyYW5nZTo3ZGU5NzIxNjA5Y2M0YTIyYWU2NGU0YWU2NWE4MDQyNl8xLTEtMS0xLTA_80fde824-7a89-420b-b94c-fc895b8bf88b">0001333493</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU3_d4d5b944-bd99-4637-ac64-72baa9ca0642">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8yMjY_91299d04-a711-4399-8c0f-9b2c260a4942">2021-03-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzUx_4f7b9d18-313a-4b28-ae7f-733b4ba4168f">EHEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6YTdjMmVjNjhkM2IyNDQ3ZmIzMzllOWI2NzdhNzYzYzgvdGFibGVyYW5nZTphN2MyZWM2OGQzYjI0NDdmYjMzOWU5YjY3N2E3NjNjOF8xLTAtMS0xLTA_d994b24f-fa91-4b28-b985-167f949b5953">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6YTdjMmVjNjhkM2IyNDQ3ZmIzMzllOWI2NzdhNzYzYzgvdGFibGVyYW5nZTphN2MyZWM2OGQzYjI0NDdmYjMzOWU5YjY3N2E3NjNjOF8xLTEtMS0xLTA_973fec35-acfd-4953-9199-950df1db7a87">001-33071</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6YTdjMmVjNjhkM2IyNDQ3ZmIzMzllOWI2NzdhNzYzYzgvdGFibGVyYW5nZTphN2MyZWM2OGQzYjI0NDdmYjMzOWU5YjY3N2E3NjNjOF8xLTItMS0xLTA_06c4762a-f5ef-4970-9899-1c0bd6190454">56-2357876</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzQ0_2281f36c-2b86-4c79-8c5e-ac3026508cfd">2625 AUGUSTINE DRIVE, SECOND FLOOR</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzUy_324b2e54-8019-41a4-915d-a50523e7388f">SANTA CLARA</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzUz_c4bdfac8-7f78-47ea-ba21-04b406135cb4">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8zNTI_f0025bf0-9217-42d2-af8a-c92fb30513d3">95054</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV80Njc_def8644f-aaf7-4561-afdd-a3edd74316f0">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzQ1_ed63e840-77f8-42cb-a3d8-178aca75ad89">584-2700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzQ3_35aa3af8-f90e-42ac-9f52-425a218a91f7">false</dei:WrittenCommunications>
    <dei:WrittenCommunications
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzQ3_b2a691f5-35e6-4b13-8168-d6c9135ebcbc">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU5_3edf3e56-d452-4fa4-a659-451b38a35c30">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU2_e4fd3675-a3cb-4733-a85b-5903e938a4be">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementTenderOffer
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU2_e57452ef-a0eb-46a4-a03f-7900dea15456">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzU0_9117dc7f-fb59-4f24-934b-a402e806f6a3">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6OTlmMTlkMGU3NDRkNDg5OTlkYzZmODU4OWE4YmU4MDIvdGFibGVyYW5nZTo5OWYxOWQwZTc0NGQ0ODk5OWRjNmY4NTg5YThiZTgwMl8xLTAtMS0xLTA_8a70551e-c9bc-40aa-b067-e9bbf8dc9ba7">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6OTlmMTlkMGU3NDRkNDg5OTlkYzZmODU4OWE4YmU4MDIvdGFibGVyYW5nZTo5OWYxOWQwZTc0NGQ0ODk5OWRjNmY4NTg5YThiZTgwMl8xLTItMS0xLTA_e6c75ecb-bdc2-47a0-a442-9251210d4a22">EHTH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGFibGU6OTlmMTlkMGU3NDRkNDg5OTlkYzZmODU4OWE4YmU4MDIvdGFibGVyYW5nZTo5OWYxOWQwZTc0NGQ0ODk5OWRjNmY4NTg5YThiZTgwMl8xLTQtMS0xLTA_46523d0f-1c7a-458c-ba76-410150455f15">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310"
      id="id3VybDovL2RvY3MudjEvZG9jOjY5NWI5MTQ4ZTcyMjRiNGU5ZTljZjMxNjM2NDAzNjVmL3NlYzo2OTViOTE0OGU3MjI0YjRlOWU5Y2YzMTYzNjQwMzY1Zl8xL2ZyYWc6ZjIzNWQ0MWE4OWU5NDI3MGE3YzFmYWU1MjhjNWM3MTkvdGV4dHJlZ2lvbjpmMjM1ZDQxYTg5ZTk0MjcwYTdjMWZhZTUyOGM1YzcxOV8xNzUw_d98e8f4b-099f-4241-8910-581d692ac8b2">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140042459028536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Mar. 10, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 10,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EHEALTH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2357876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2625 AUGUSTINE DRIVE, SECOND FLOOR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">SANTA CLARA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">95054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">584-2700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EHTH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001333493<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M:C&H-UO58UB7I6J//X7W*+F?&^[_$L4/4$L#!!0    ( $U$:U*7BKL<P
M !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6
MH@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.
MD4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,
M<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW'
M]I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ 341K
M4AE%%?4W 0  )P(   \   !X;"]W;W)K8F]O:RYX;6R-4=%NPC ,_)4J'[ 6
MM"$-45Y VY"F#8V)]]"ZU"*)*\>%C:^?VZH:TE[VE-S9NMQ=%A?BTX'HE'QY
M%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P9:P!Q+MTFF6SU%L,9KD8M;:<
MW@(2* 0I*-D1>X1+_)UW,#ECQ ,ZE._<]'<')O$8T.,5RMQD)HDU75Z(\4I!
MK-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-Y&:6J6"%'*7?Z/6M>CR#+@^H
M%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_4R-5%1:PIJ+U$&3HD<%U!D.L
ML8DF"=9#;E9T!DZV]@A=*'UE4PX!19W=U,5SU %ORL'C:*R$"@.4;ZH5E=>2
MBBTGW='K3.\?)H]:1NO<2KGW\$JV''..?[3\ 5!+ P04    " !-1&M2)!Z;
MHJT   #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P
M#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=N
MH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFB
MG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6
M<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ 341K
M4F60>9(9 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O
M$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1
ML.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3K
MU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY8
M4(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"
MJ;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R
M]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>
M?P%02P$"% ,4    " !-1&M2!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $U$:U)!41TA[@   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( $U$:U*97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ 341K4C;00Q) !   0!   !@
M         ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( $U$:U*#J:4#U $  #(&   -              "  8,,  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ 341K4I>*NQS     $P(   L
M ( !@@X  %]R96QS+RYR96QS4$L! A0#%     @ 341K4AE%%?4W 0  )P(
M  \              ( !:P\  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M $U$:U(D'INBK0   /@!   :              "  <\0  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $U$:U)ED'F2&0$  ,\#   3
M              "  ;01  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  /X2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ehth-20210310.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ehealthinsurance.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ehth-20210310.htm">ehth-20210310.htm</File>
    <File>cooperationagreement.htm</File>
    <File>ehth-20210310.xsd</File>
    <File>ehth-20210310_cal.xml</File>
    <File>ehth-20210310_def.xml</File>
    <File>ehth-20210310_lab.xml</File>
    <File>ehth-20210310_pre.xml</File>
    <File>ex991pressreleasecooperati.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ehth-20210310.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "ehth-20210310_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ehth-20210310_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ehth-20210310.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ehth-20210310_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ehth-20210310_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "ehth-20210310.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ehth",
   "nsuri": "http://www.ehealthinsurance.com/20210310",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210310.htm",
      "contextRef": "i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.ehealthinsurance.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ehth-20210310.htm",
      "contextRef": "i358a99fbf3f340b5934233090f28e1aa_D20210310-20210310",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ehealthinsurance.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001333493-21-000024-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001333493-21-000024-xbrl.zip
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MUEU_3]PID:H!G HX TH"1]2KKX6#RX1A:V33-^%"@C+7B+47Q&4,>_=P]3:
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M#?/"D86W?@6#*8>?K01AB#2BX.-AIIF/<UPC>8=7911:4E_]D8R'RF4S7OV
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MY2H66^U=9WB/]0BI)AVA^S75.I/\#(U^M?8SY0H["I0ZHBZ+="0VYK%F(,5
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MN,]>9F"GB+-:J;D:PV[(G3#8_E?0OE:4]I4;!"V_-W+]7WD)Y=AXE?S&0&7
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M1-.'N(>^]WK,Y?ZM3WE:B2,NGGYS9E+EB4L\_,T9\B*6N!'K/<,5%WF9+^&
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M_%=<<=NXK3_5!55JF&(2.S4W=2TD+OA2T?)17<#<V<6UTMRAFKK!U%8C0_?
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MM&:#>.##5$=G[T)L[)YB?R$Z7F8O&KL5)_.-8"C";)0KQAFYZT(J/-6$Q)
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M;>U=ZU?C.++_OG^%;N;>63@G#GXF-MW-GDP2Z,R0A(;0+'SAR+:<&!P[8SM
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M0X<5LO:!'UX^T!QOVS29-+^YT_Y:XZT5R[*V^-V\J<NF=/!.$^:4>M'5%MR
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MY9_WL7<6/FW9D3N&?R R#G;^'U!+ P04    " !-1&M2]<Z:Y9 "  "<"0
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M$?$43QR^N?NC.W2;]@_?_ ]02P,$%     @ 341K4M&SF^OD#0  <3<  !X
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MK70I/7Q:ZN[%=]'';'W^N+:_&H_Q##FJ#*IV#*J6V%CCO'(MMHT8.10@+SQ
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MX0384@+>_; ITNDV=_;VFKN[N\\VO"YMQS]&XS^+._DO4$L! A0#%     @
M341K4F7P.Q!71   <,0! !@              ( !     &-O;W!E<F%T:6]N
M86=R965M96YT+FAT;5!+ 0(4 Q0    ( $U$:U*,7KT[;1T  'ZR   1
M          "  8U$  !E:'1H+3(P,C$P,S$P+FAT;5!+ 0(4 Q0    ( $U$
M:U+USIKED (  )P)   1              "  2EB  !E:'1H+3(P,C$P,S$P
M+GAS9%!+ 0(4 Q0    ( $U$:U*DQ"*.B@$  .("   5              "
M >AD  !E:'1H+3(P,C$P,S$P7V-A;"YX;6Q02P$"% ,4    " !-1&M27%]]
M]1 "  "+!@  %0              @ &E9@  96AT:"TR,#(Q,#,Q,%]D968N
M>&UL4$L! A0#%     @ 341K4H5OV@\^"@  HET  !4              ( !
MZ&@  &5H=&@M,C R,3 S,3!?;&%B+GAM;%!+ 0(4 Q0    ( $U$:U+_9"N;
ML 8  ((Q   5              "  5ES  !E:'1H+3(P,C$P,S$P7W!R92YX
M;6Q02P$"% ,4    " !-1&M2T;.;Z^0-  !Q-P  '@              @ $\
M>@  97@Y.3%P<F5S<W)E;&5A<V5C;V]P97)A=&DN:'1M4$L%!@     (  @
*' (  %R(      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
